GPR19 Drives Cell Cycle Progression via ERK-Dependent FOXM1 Activation in p53-Mutant Breast Cancer
Jihan Qiu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Shengchun Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Yang Peng(Liaocheng University), Kuan He(The Affiliated Yongchuan Hospital of Chongqing Medical University), Cheng Tian(Huazhong University of Science and Technology), Qiuyan Luo(The Affiliated Yongchuan Hospital of Chongqing Medical University), Haochen Yu(St. Michael's Hospital), Chengcheng Yang(Harbin Medical University), Sumei Gao(The Affiliated Yongchuan Hospital of Chongqing Medical University), Kang Li(The Affiliated Yongchuan Hospital of Chongqing Medical University), Lingfeng Tang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Yang Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University), H. Li(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Cited by 0
Related Papers
Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease
|The International Journal of Neuropsychopharmacology|2011|430
Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
|Oncogene|2016|430
Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor
|Oncology Reports|2019|223
Diagnostic Value of Circulating Chromogranin A for Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
|PLoS ONE|2015|101
CXCL1 stimulates migration and invasion in ER‑negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis
|International Journal of Oncology|2019|77